NATCO Pharma Limited (NSE:NATCOPHARM)

NATCO Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	158,886	174,489	143,064	170,522	102,795	138,013
Market Cap Growth	11.05%	21.97%	-16.10%	65.89%	-25.52%	-8.31%
Enterprise Value	144,734	145,097	124,852	160,841	93,605	133,992
Last Close Price	808.80	964.63	786.33	932.79	545.94	726.25

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	12.68	12.30	7.59	12.28	14.37	81.18
Forward PE	18.58	20.41	7.58	11.66	10.02	16.05
PS Ratio	4.56	4.28	3.23	4.26	3.80	7.09
PB Ratio	1.72	1.89	1.88	2.91	2.11	3.24
P/TBV Ratio	1.77	1.95	1.95	3.01	2.19	3.34
P/FCF Ratio	11.51	12.64	11.04	19.55	14.63	-
P/OCF Ratio	8.99	9.87	8.43	14.07	12.11	296.80
PEG Ratio	-	0.27	0.25	0.49	0.20	0.24

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	4.15	3.56	2.82	4.02	3.46	6.89
EV/EBITDA Ratio	12.06	9.96	5.82	9.19	9.68	51.54
EV/EBIT Ratio	14.67	11.53	6.35	10.24	11.56	108.58
EV/FCF Ratio	10.49	10.51	9.64	18.44	13.32	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.08	0.08	0.04	0.07	0.04	0.10
Debt / EBITDA Ratio	0.67	0.49	0.13	0.22	0.18	1.64
Debt / FCF Ratio	-	0.52	0.22	0.44	0.25	-
Net Debt / Equity Ratio	-0.15	-0.15	-0.29	-0.17	-0.13	-0.08
Net Debt / EBITDA Ratio	-1.32	-0.97	-1.03	-0.57	-0.64	-1.26
Net Debt / FCF Ratio	-	-1.02	-1.71	-1.15	-0.88	1.76
Asset Turnover	-	0.41	0.57	0.64	0.50	0.39
Inventory Turnover	-	0.80	0.89	0.94	0.78	0.66
Quick Ratio	-	1.84	4.07	2.73	2.47	2.02
Current Ratio	-	3.01	5.59	4.14	4.39	3.50
Return on Equity (ROE)	-	16.85%	27.97%	25.88%	15.66%	4.05%
Return on Assets (ROA)	-	7.98%	15.82%	15.63%	9.40%	1.56%
Return on Invested Capital (ROIC)	10.16%	17.58%	31.53%	28.62%	16.41%	2.76%
Return on Capital Employed (ROCE)	-	13.40%	25.60%	26.50%	16.30%	2.80%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	7.89%	8.13%	13.18%	8.14%	6.96%	1.23%
FCF Yield	8.69%	7.91%	9.06%	5.12%	6.84%	-1.35%
Dividend Yield	0.62%	0.51%	0.75%	1.00%	0.98%	0.60%
Payout Ratio	7.04%	6.36%	5.72%	12.30%	14.04%	48.35%
Buyback Yield / Dilution	0.00%	-	0.21%	1.67%	-0.08%	0.04%
Total Shareholder Return	0.62%	0.51%	0.97%	2.67%	0.90%	0.64%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error